Yamauchi, Paul, 7David Geffen School of Medicine at UCLA, Los Angeles, and Dermatology Institute & Skin Care Center, Inc., Santa Monica, CA, USA, United States

• SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Poster Presentations from FC21 Dermatology Conference®: Psoriasis
  Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials
  Abstract  Poster PDF